Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 25th World Congress on Neurology & Neuroscience Finnstown Castle Hotel, Dublin, Ireland.

Day 1 :

Keynote Forum

Patricia A. Quigley

Nurse Consultant LLC, USA

Keynote: Redesigning fall and fall injury prevention strategies for stroke patients

Time : 10:00-11:00

OMICS International Neuroscience Congress 2018 International Conference Keynote Speaker Patricia A. Quigley photo
Biography:

Dr. Patricia Quigley, PhD, ARNP, CRRN,  FAAN, FAANP,  Nurse Consultant, both a Clinical Nurse Specialist and a Nurse Practitioner in Rehabilitation.  Her contributions to patient safety, nursing and rehabilitation are evident at a national and international level – with emphasis on clinical practice innovations designed to promote elders’ independence and safety.  For over 40 years, Dr. Quigley has practice in the field of rehabilitation nursing, 32.5 years with the Veterans Administration. Her leadership resulted in redesign measurement of patient safety indicators for falls and fall injuries that link organizational unit and patient-level variables that are relevant and evidencebased. She has conducted large-scale studies to examine trends and cost savings on national interventions to reduce harm from falls.  Dr. Quigley has served as principal or co-investigator in 35 research studies, totaling over $7.5 million. She has a track record of interdisciplinary research with health economists, epidemiologists, and statisticians for population-based outcomes research. She has co-authored and served as associate director for 11 VISN 8 Patient Safety Center of Inquiry center grants from 1999-2016, totaling over $13 million. She has authored, co-authored over 60 peer-reviewed manuscripts and over 50 non-peer reviewed manuscripts,  book chapters,  products and media works.  She provides on going consultation to the nursing staff, quality management, and patient safety coordinators for management of complex patients at risk for falls.
 

Abstract:

Falls and fall-related injuries remain a frequent complication of strokes. Fall and injury prevention based on fall risk scores and level of fall risk, such as low, moderate or high, is insufficient, requiring that clinicians redesign fall prevention programs based on patient’s individualized fall and injury risk factors. Accepting that stroke is one of the leading causes of disability world-wide, all efforts should be made to protect these patients from falls and fall-related injuries. It is well known that falls result in fear of falling, greater disability and even loss of life. While the evidence for stroke-specific fall prevention interventions is still emerging, clinical experts must rely on clinical expert knowledge to conduct stroke-specific fall risk assessment needed to individualize fall prevention plans of care, while assuring injury risk and prevention strategies are included. This population-based approach presented in this lecture redesigns traditional universal programs in order to enhance infrastructure and capacity to individualized fall and injury risk factors and history, and protection from injury should a fall occur. Increased attention is essential to protect stroke patients from fall-related injuries. Clinical expertise is essential for safe practices for these patients. Equipment use specifically designed to reduce trauma during a fall, such as hip protectors and floor mats, must be reliably integrated into patient care. Even though acute care units have diverse patients, known fall and injury risk factors specific to type and severity of stroke must be implemented and tested for effectiveness.

Keynote Forum

Char-Nie Chen

Chinese University of Hong Kong, Hong Kong

Keynote: Novel ideas in sleep medicine

Time : 11:20-12:00

OMICS International Neuroscience Congress 2018 International Conference Keynote Speaker Char-Nie Chen photo
Biography:

Char-Nie Chen has completed his Graduation in Medicine from the National Taiwan University (NTU). He is trained in Psychiatry at NTU and St. George’s Hospital Medical School, London (SGHMS), UK. He completed his MSc in Department of Physiology, University College London. He was a Lecturer and Senior Lecturer in Psychiatry at SGHMS and; Founding Professor of Psychiatry, Faculty of Medicine, Chinese University of Hong Kong (CUHK) from 1981 to 1998. His professional orientation is in Psychosomatic Medicine, and he has worked on eating disorders, sleep disorders, mood disorders, substance use disorders as well as psychiatric problems in PLHIV/ AIDS. Currently, he is a Clinical Professor of Psychiatry at CUHK and a Specialist in Psychiatry in Hong Kong. He is a Fellow of the Royal College of Psychiatrists, Royal Australian and New Zealand College of Psychiatrists and Past President and Honorary Fellow of the Hong Kong College of Psychiatrists.

 

Abstract:

Sleep medicine lags behind other medical disciplines because of the complexity in neurosciences, especially in discrete brain areas related to sleep-wake mechanisms. With the advancement of biotechnology and neurobiology, new ideas have emerged in sleep medicine. For example, new imaging technique has found out that the brain GABA level was reduced in un-medicated primary insomniacs. Sleep-wake cycle disturbances may be used for early diagnosis of neurocognitive disorders with aberrant tau protein, as it was found to be a cause for the damage of neurons in patients with neurocognitive disorders leading to sleep disturbance which may be used to pathological fibrillation of alpha-synuclein protein, leading to the formation of Lewy bodies, could be prevented by monoclonal antibodies against Epstein-Barr virus, or a rosmarinic acid or cuminaldehyde. The possible biomarker of rapid-eyemovement sleep behaviour disorder (RSBD) may help in earlier diagnosis and treatment for Parkinson’s disease. This point towards a direction for future treatment of alpha-synucleinopathies including Parkinson’s Disease and their sleep problems. The central pathology may give a new direction of management for patients with Alzheimer’s disease or others with tauopathy.